NASDAQ
Total Transactions
1
0 buys /1 sells
Shares Acquired
0
Transactions: 0•Avg: 0
Shares Disposed
1,395
Transactions: 1•Avg: 1,395
Net Activity
-1,395
Net Selling•Ratio: 0%
Q4 2025(Current) | 0 | 1,395 | -1,395 | 0.00% |
Q2 2025 | 269,824 | 33,446 | +236,378 | 480.00% |
Q1 2025 | 642,127 | 17,858 | +624,269 | 262.50% |
Q4 2024 | 0 | 1,531 | -1,531 | 0.00% |
Q2 2024 | 108,400 | 0 | +108,400 | 0.00% |
This table shows insider trading activity by quarter. A ratio > 100% indicates insiders acquired more shares than they disposed of during the period, which is generally considered a bullish signal.
• Most recent data for Q4 2025
Acquired vs Disposed Shares
Net Distribution: 1,395 shares•Acquired/Disposed Ratio: 0%
Net Activity | |||||
|---|---|---|---|---|---|
FR Farid Ramy | Director, officer: president & ceo | 5 | 400,771 | 0 | +400,771 |
AK Akinsanya Karen | Officer: president of r&d, therapeutics | 10 | 214,848 | 33,446 | +181,402 |
PGC Porges Geoffrey Craig | Officer: evp & cfo | 7 | 176,350 | 8,806 | +167,544 |
LKP Lorton Kenneth Patrick | Officer: evp, cto & coo, software | 7 | 158,074 | 6,559 | +151,515 |
ARL Abel Robert Lorne | Officer: see remarks | 6 | 152,500 | 2,430 | +150,070 |
This table shows the trading activity of the most active company insiders. Positive net activity (buying more than selling) is often considered a bullish signal.
2025-10-16 | Officer: chief medical officer | Sale | 1,395 | $21.07 | $29,387.07 | 24,574 | |
2025-06-18 | Director | Purchase | 5,997 | $0 | $0 | 17,247 | |
2025-06-18 | Director | Purchase | 9,341 | $21.05 | $196,628.05 | 9,341 | |
2025-06-18 | Director | Purchase | 5,997 | $0 | $0 | 17,247 | |
2025-06-18 | Director | Purchase | 9,341 | $21.05 | $196,628.05 | 9,341 |
This table displays recent Form 4 filings showing transactions by company insiders. SEC rules require insiders to report their transactions within two business days.
DM Dugan Margaret | Officer: chief medical officer | Oct 17, 2025 | |
CJ Chodakewitz Jeffrey | Director | Jun 20, 2025 | |
CJ Chodakewitz Jeffrey | Director | Jun 20, 2025 | |
SG Sender Gary | Director | Jun 20, 2025 | |
SG Sender Gary | Director | Jun 20, 2025 |
Net change in shares shown on right
No price data available for this timeframe.